NASDAQ:REVH

Revolution Healthcare Acquisition (REVH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$10.04
$10.04
50-Day Range
$10.01
$10.06
52-Week Range
$9.62
$10.50
Volume
371 shs
Average Volume
183,205 shs
Market Capitalization
$476.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
REVH stock logo

About Revolution Healthcare Acquisition Stock (NASDAQ:REVH)

Revolution Healthcare Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in health care, life sciences, and technology industries. The company was incorporated in 2021 and is based in Cambridge, Massachusetts.

REVH Stock News Headlines

The therapy revolution
His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
Revolution Healthcare Acquisition Corp. (REVH)
His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
Revolution Healthcare Acquisition Corp (REVH)
Putin 'misled' by Russian military: White House
See More Headlines
Receive REVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Revolution Healthcare Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:REVH
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Net Income
$21.35 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.49 per share
Book Value
($0.74) per share

Miscellaneous

Free Float
46,919,000
Market Cap
$476.93 million
Optionable
Not Optionable
Beta
0.04
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Dr. Jay S. Markowitz M.D. (Age 60)
    CEO & Director
  • Mr. Mark A. McDonnell CPA (Age 53)
    CPA, Chief Financial Officer
  • Mr. Paul Fielding (Age 35)
    Chief Operating Officer
  • Mr. Jason Doren (Age 52)
    Chief Admin. Officer

This page (NASDAQ:REVH) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners